For ocular use only. Tilt head back, pull down the lower eyelid to form a pouch, and instill the prescribed number of drops. Do not touch the dropper tip to the eye or any other surface to avoid contamination. Close eyes gently for 1-2 minutes after administration to minimize systemic absorption.

Timolol Maleate acts by reducing the production of aqueous humor in the ciliary body, thereby lowering intraocular pressure. It does not significantly affect pupil size or visual acuity.

• •Bronchial asthma or a history of bronchial asthma, severe chronic obstructive pulmonary disease (COPD).
• •Sinus bradycardia, second or third-degree atrioventricular block, overt cardiac failure, cardiogenic shock.
• •Hypersensitivity to Timolol Maleate or any component of the formulation.

Store below 30°C. Do not freeze. Protect from light and moisture. Keep out of reach of children.

Symptoms of systemic overdose may include bradycardia, hypotension, bronchospasm, and acute cardiac failure. Treatment is symptomatic and supportive; atropine may be used for bradycardia, and beta-agonists for bronchospasm.

Use in pregnancy only if the potential benefit justifies the potential risk to the fetus. Caution advised during lactation as Timolol is excreted in breast milk and may cause serious adverse reactions in nursing infants. A decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.